PRINCY DANIEL: Open Payments
NPI 1184189292 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,131 in 120 payments from 9 companies in 2025. Trend: 2023 $1,525 · 2024 $2,435 · 2025 $3,131
Food & beverage: $3,046Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 45 | $1,506 |
| ABBVIE INC. | 26 | $597 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $438 |
| Lilly USA, LLC | 16 | $200 |
| QOL Medical, LLC | 4 | $148 |
| Celltrion USA Inc. | 4 | $93 |
| Aimmune Therapeutics, Inc. | 4 | $90 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
Products named: TREMFYA, ENTYVIO, RINVOQ, SKYRIZI, OMVOH, Sucraid, VEGZELMA, VOWST.
Industry payments across NY — which companies pay providers there.
